Characterization of the Nutritional Status in the Patient With Liver Cirrhosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-01

Study Completion Date

2019-08-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the subgroup of patients with sarcopenia, regardless of their body mass index, we want to verify the real impact of nutritional supplements with branched chain amino acids on the standard treatment based on nutritional intervention and physical exercise.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Benefit of Exercise and Aminoacid Supplements in Cirrhotic Patients

NCT01060813

Cirrhosis

COMPLETED NA

Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis

NCT02023229

Liver Cirrhosis

COMPLETED PHASE4

Nutritional Assesment in Patients With Cirrhosis

NCT05729438

Cirrhosis, Liver

RECRUITING

Impact of Dietary Assessment and Intervention on Outcomes in Liver Cirrhosis Patients

NCT05259930

Sarcopenia Cirrhosis, Liver

RECRUITING NA

Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial Intervention

NCT04243148

Cirrhosis of the Liver Sarcopenia Frailty Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BRCA

They were in treatment with BRCA and standard treatment based on nutritional intervention and physical exercise.

Group Type ACTIVE_COMPARATOR

Branched chain amino acids (BRCA)

Intervention Type DIETARY_SUPPLEMENT

They were with BRCA during the day apart of following the standard recommendations

Placebo

They only were on standard treatment based on nutritional intervention and physical exercise.

Group Type PLACEBO_COMPARATOR

Branched chain amino acids (BRCA)

Intervention Type DIETARY_SUPPLEMENT

They were with BRCA during the day apart of following the standard recommendations

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Branched chain amino acids (BRCA)

They were with BRCA during the day apart of following the standard recommendations

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cirrhotic patients with sarcopenia in abdominal CT.

Exclusion Criteria

* chronic renal failure or being on hemodialysis
* active hepatitis B or C virus infection
* active alcohol abuse
* coinfection with human immunodeficiency virus
* renal or previous liver transplantation
* history of neoplasia requiring chemotherapy or radiotherapy
* hepatocellular carcinoma outside of Milan criteria
* TIPs
* unwillingness to participate in the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No